Eris Lifesciences Ltd
NSE:ERIS

Watchlist Manager
Eris Lifesciences Ltd Logo
Eris Lifesciences Ltd
NSE:ERIS
Watchlist
Price: 1 417.35 INR 0.85% Market Closed
Market Cap: 193B INR

EV/FCFF
Enterprise Value to FCFF

34
Current
32.5
Median
18.3
Industry
Higher than median
Higher than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
34
=
Enterprise Value
210.9B INR
/
FCFF
6.2B INR
Market Cap EV/FCFF
IN
Eris Lifesciences Ltd
NSE:ERIS
192.8B INR 34
US
Eli Lilly and Co
NYSE:LLY
761.5B USD 1 898.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 13 236.9
US
Johnson & Johnson
NYSE:JNJ
400.1B USD 20.7
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK 30.8
CH
Roche Holding AG
SIX:ROG
231.8B CHF 47.4
UK
AstraZeneca PLC
LSE:AZN
174.2B GBP 337.4
CH
Novartis AG
SIX:NOVN
198.4B CHF 17.3
US
Merck & Co Inc
NYSE:MRK
225.2B USD 16.6
IE
Endo International PLC
LSE:0Y5F
167.6B USD 1 028.2
US
Pfizer Inc
NYSE:PFE
141.5B USD 23.8

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Summary
ERIS intrinsic value, competitors valuation, and company profile.
DCF Valuation
ERIS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ERIS stock valuation using valuation multiples.
Wall Street Estimates
ERIS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ERIS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.